TECX

Conviction 69HealthcareScan · Fri, Jun 26, 2026

Hanging man

TECX$31.95+2.96%

ResistanceSupportVol 14Insider sell

Vol MA14 138.72K

Mar 27Apr 15May 4May 20Jun 9Jun 26

Tectonic Therapeutic, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.tectonictx.com ↗

Price31.95

Change+2.96%

Gap+1.61%

Rel volume2.89×

Avg volume145.36K

Avg $ vol4.34M

SMA 2029.67

SMA 5029.04

SMA 20023.42

Price vs 50+10.01%

Price vs 200+36.45%

MA stackbullish

50/200 cross—

Supertrendup · 26.09

RSI (14)64

MACD hist0.23

MACD crossbull · 9d

Stoch %K / %D95 / 87

ADX (14)14

+DI / −DI20 / 14

RSI divergence—

MACD divergence—

ATR %+5.50%

ADR %6.04%

52w high35.87

52w low14.71

From 52w high-10.93%

Above 52w low+117.20%

New 52w highNo

SqueezeOn · 40d

Bollinger width14.99%

%B1.01

Donchian pos94.74%

Donchian high32.23

Donchian low27.00

AVWAP (52w high)30.17

vs AVWAP high+5.91%

AVWAP (52w low)22.23

vs AVWAP low+43.74%

OBV trendUp

Chaikin MF (20)0.08

Today vs 20d2.89×

Avg vol (14d)138.72K

Avg vol (20d)145.36K

Avg $ vol (20d)4.34M

Market cap—

RS 3m (vs SPY)-11.89%

RS 6m (vs SPY)+37.71%

RS line new highNo

Trend template7/8

Technical rank88.4

1 week+6.43%

1 month+5.00%

3 months+3.87%

6 months+49.93%

1 year+57.00%

YTD+52.80%

P/E-7.91

P/B2.55

P/S—

P/FCF-9.73

EPS-4.05

Div yield—

ROE-32.18%

ROA-30.07%

Debt/Eq0.07

Current18.51

EV/EBITDA-4.41

Gross margin—

Net margin—

Rev growth—

EPS growth-27.89%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value364.75M

Revenue—

Net income-25.24M

Gross profit—

Free cash flow-60.29M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out18.87M

Employees60

ListedFri, Jun 21, 2024

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeB

Conviction69 / 100

Pattern quality—

Tech rank88.4 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmHanging man

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in TECX

All disclosures →

No recent disclosed trades by Congress in TECX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in TECX · 5 buys · 1 sell

Insider	Side	Shares	Value	Traded	Filed
Vitorovic Stefan Director · Stock Option (Right to Buy) · 2026-06-09	Grant	10.2K	$0	2026-06-09	2026-06-10
Donenberg Phillip B. Director · Stock Option (Right to Buy) · 2026-06-09	Grant	10.2K	$0	2026-06-09	2026-06-10
Tipirneni Praveen P. Director · Stock Option (Right to Buy) · 2026-06-09	Grant	10.2K	$0	2026-06-09	2026-06-10
SPRINGER TIMOTHY A Director · Stock Option (Right to Buy) · 2026-06-09	Grant	10.2K	$0	2026-06-09	2026-06-10
Chutter Jessica Caroline Director · Stock Option (Right to Buy) · 2026-06-08	Grant	20.4K	$0	2026-06-08	2026-06-10
Ruddy Marcella K. Chief Medical Officer · Common Stock · 2026-05-04	Sell	1.06K	$32K	2026-05-04	2026-05-06

SEC filings

EDGAR filings in TECX · 1 recent

EDGAR →

8-K8-KWed, Jun 10, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.